2023 Form 5500 filing — Celldex Therapeutics, Inc. Welfare Benefit Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240721170908NAL0016262752001) for Celldex Therapeutics, Inc. Welfare Benefit Plan, reported by Celldex Therapeutics, Inc. under EIN 13-3191702 and plan number 501. It reports 150 participants. Attached schedule details are not reported in the loaded dataset.

EFAST2 acknowledgement
20240721170908NAL0016262752001
Filing year
2023
Form type
2
Plan sponsor
Celldex Therapeutics, Inc.
EIN
13-3191702
Plan number
501
Location
Needham, MA
Participants
150
Schedules available
Not reported in the loaded dataset
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

This 2023 filing is loaded, but detailed Schedule H/I financial figures are not present for it in the current loaded dataset. Participant counts and filing identity above are reported; asset and contribution detail comes from the financial schedules where filed.

Related Form 5500 pages